Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
The Korean Journal of Internal Medicine ; : 94-99, 2008.
Artigo em Inglês | WPRIM | ID: wpr-206217

RESUMO

BACKGROUND/AIMS: Coagulopathy is a common complication of snakebite, but there is little information on the clinical importance of coagulopathy. We analyzed the characteristics of coagulopathy after envenomation. METHODS: Ninety-eight patients who experienced snakebite were enrolled in this study. We divided all the patients into three groups by the ISTH DIC scoring system: the normal, simple coagulopathy and DIC groups. The coagulopathy group included both the simple coagulopathy and DIC groups. We then conducted a case-control study. RESULTS: There was a significant decrease in the Hct, protein, albumin, ALP and cholesterol levels in the coagulopathy group, and only the cholesterol level was deceased in the DIC group (p<0.05). Leukocytosis and rhabdomyolysis were significantly associated with coagulopathy, and hemolysis and rhabdomyolysis were associated with DIC (p<0.05). The presence of rhabdomyolysis was considered a risk factor for coagulopathy (p<0.05). These conditions continued for up to six to seven days after the snakebite. CONCLUSIONS: Evaluation of coagulopathy with using these characteristics is helpful to properly manage the patients who experience snakebite.


Assuntos
Animais , Feminino , Humanos , Masculino , Transtornos da Coagulação Sanguínea/etiologia , Estudos de Casos e Controles , Hemólise/efeitos dos fármacos , Incidência , Leucocitose/etiologia , Estudos Retrospectivos , Rabdomiólise/etiologia , Fatores de Risco , Mordeduras de Serpentes/complicações
2.
Tuberculosis and Respiratory Diseases ; : 515-520, 2007.
Artigo em Coreano | WPRIM | ID: wpr-134821

RESUMO

Mycoplasma pneumoniae (M. pneumoniae) is the leading cause of pneumonia in older children and young adults. Normally, it does not progress to a condition requiring hospitalization but improves spontaneously or has a mild clinical course. We report two cases of M. pneumoniae pneumonia with different clinical manifestations from the normal course. The patients were young healthy individuals. The diagnoses were made by serology. However, it could not be determined beforehand that they had M. pneumoniae pneumonia. Based on the empirical treatment strategy of severe community acquired pneumonia, the patients were treated with broad-spectrum antibiotics including cephalosporin, quinolone and macrolide. After administering the antibiotics, they showed a gradually favorable clinical course and recovered without residual complications. A M. pneumoniae infection should be considered as a cause of severe community acquired pneumonia, and empirical treatment targeting this organism might be helpful in treating patients with the severe manifestation.


Assuntos
Criança , Humanos , Adulto Jovem , Antibacterianos , Diagnóstico , Hospitalização , Mycoplasma pneumoniae , Mycoplasma , Pneumonia , Pneumonia por Mycoplasma
3.
Tuberculosis and Respiratory Diseases ; : 515-520, 2007.
Artigo em Coreano | WPRIM | ID: wpr-134820

RESUMO

Mycoplasma pneumoniae (M. pneumoniae) is the leading cause of pneumonia in older children and young adults. Normally, it does not progress to a condition requiring hospitalization but improves spontaneously or has a mild clinical course. We report two cases of M. pneumoniae pneumonia with different clinical manifestations from the normal course. The patients were young healthy individuals. The diagnoses were made by serology. However, it could not be determined beforehand that they had M. pneumoniae pneumonia. Based on the empirical treatment strategy of severe community acquired pneumonia, the patients were treated with broad-spectrum antibiotics including cephalosporin, quinolone and macrolide. After administering the antibiotics, they showed a gradually favorable clinical course and recovered without residual complications. A M. pneumoniae infection should be considered as a cause of severe community acquired pneumonia, and empirical treatment targeting this organism might be helpful in treating patients with the severe manifestation.


Assuntos
Criança , Humanos , Adulto Jovem , Antibacterianos , Diagnóstico , Hospitalização , Mycoplasma pneumoniae , Mycoplasma , Pneumonia , Pneumonia por Mycoplasma
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA